The Strategic Plan Clause Samples
The Strategic Plan clause outlines the requirement for the parties to develop, agree upon, and periodically update a comprehensive plan that sets forth the long-term goals, objectives, and key initiatives for their collaboration or project. Typically, this clause specifies the process for drafting the plan, the timeline for its completion, and the responsibilities of each party in contributing to and approving the plan. By establishing a clear framework for strategic direction, this clause ensures alignment between the parties and provides a structured approach to achieving shared objectives, thereby reducing misunderstandings and facilitating coordinated action.
The Strategic Plan. The Strategic Plan is a high level expression of the priorities for Rotorua Girls High School for the period 2016 – 2018. The Strategic Plan guides the Board’s aims and purposes so that the Board can allocate resources to the school and monitor the school’s overall performance. The Strategic Plan is supported by an Annual Plan and on the annual budget approved by the Board each year. The Strategic Plan is owned by the Board of Trustees and is adopted by the Board following consultation with stakeholders. Responsibility for implementation of the Strategic Plan rests with the Principal and staff. It is the Board’s task to hold the school’s management accountable for achievement of the goals described in this plan but the overall responsibility for achieving these goals rests ultimately with the Board. We will achieve our aims by working on our stated objectives and through identified directions. The Board will measure performance and success by examining the agreed targets and performance indicators. Our plan describes how we will achieve five strategic priorities.
The Strategic Plan. Subject to and in accordance with the terms of this Agreement, Akcea will Develop and Commercialize Products in accordance with a global strategic Development and Commercialization plan (the “Strategic Plan”). The Strategic Plan will cover both the long-term global strategy for each of the Products separately, and as a suite of products, as well as, on a rolling basis, the more detailed activities Akcea and Isis will perform over the course of the next 24 months. The Parties have agreed to (i) an initial Strategic Plan as of the Effective Date, which is comprised of the published development plans for each of the Lipid Drugs, and (ii) meet in person or hold a telephone conference at least Quarterly to discuss the Strategic Plan. In addition, Akcea and Isis will meet more often as mutually agreed on an ad-hoc basis to address any urgent matters that arise with respect to the Products. The Strategic Plan is intended to evolve over time and become more detailed (particularly with regard to Commercialization and pre- Commercialization activities) as each of the Products moves closer to market. The Strategic Plan will include, as appropriate, the following:
i. Indications Akcea will pursue for each Product (which indications will be added to and/or refined over time) and the on-going pre-clinical Research, including registries and natural history studies, in support of such indications;
ii. Timing and launch sequence of initial and subsequent indications for each Product;
iii. Clinical Trials, including patient populations, study designs, primary and secondary endpoints, length and size of study, associated timelines and budgets, that the Parties will conduct for each Product;
iv. Safety data delivery procedures governing the collection, investigation, reporting, and delivery of information between the Parties concerning any adverse experiences, and any product quality and product complaints involving adverse experiences related to, or class effects that could impact, the Products, sufficient to enable the Parties to comply with its legal and regulatory obligations and internal processes, as applicable;
v. Global regulatory strategy, including timing and key implementation items to support each targeted indication;
vi. Timing, budget and design of all non-clinical studies supporting the Development of the Products;
vii. Upcoming scientific, development or commercial events of Akcea or competitors that may impact the Products;
viii. Publication plan (including s...
The Strategic Plan. The AEWA Strategic Plan provides a coherent and strategic framework for implementation of the Agreement by its constituents: the Contracting Parties, its subsidiary bodies (the Standing Committee and the Technical Committee), its Secretariat and the partners to the Agreement. The first Strategic Plan for AEWA was adopted at the 4th session of the Meeting of the Parties.
The Strategic Plan. The Parties will Develop and Commercialize the Products in accordance with this Agreement and pursuant to a global strategic Development and Commercialization plan (the “Strategic Plan”).
The Strategic Plan a) The Management Board shall approve and submit annually to the Minister a five-year rolling strategic plan that sets out the strategic goals and plans of the Agency for the following five years.
b) The strategic plan shall be rolled forward and updated each year and will form the agreed basis for Agency's detailed planning. It will also provide a framework for monitoring progress against longer-term objectives and targets.
c) The strategic plan shall be submitted on or before the 31st December each year and include the following:
i. the strategic goals and objectives of the Agency with reference to the fulfilment of the role of the Agency as provided for in this Agreement;
ii. reference to the strategy for training and career development plans for observers and other staff; and
iii. reference to the strategy for capacity building.
